Funke, K.; Düster, R.; Wilson, P.D.-G.; Arévalo, L.; Geyer, M.; Schorle, H.
Transcriptional CDK Inhibitors as Potential Treatment Option for Testicular Germ Cell Tumors. Cancers 2022, 14, 1690.
https://doi.org/10.3390/cancers14071690
AMA Style
Funke K, Düster R, Wilson PD-G, Arévalo L, Geyer M, Schorle H.
Transcriptional CDK Inhibitors as Potential Treatment Option for Testicular Germ Cell Tumors. Cancers. 2022; 14(7):1690.
https://doi.org/10.3390/cancers14071690
Chicago/Turabian Style
Funke, Kai, Robert Düster, Prince De-Graft Wilson, Lena Arévalo, Matthias Geyer, and Hubert Schorle.
2022. "Transcriptional CDK Inhibitors as Potential Treatment Option for Testicular Germ Cell Tumors" Cancers 14, no. 7: 1690.
https://doi.org/10.3390/cancers14071690
APA Style
Funke, K., Düster, R., Wilson, P. D.-G., Arévalo, L., Geyer, M., & Schorle, H.
(2022). Transcriptional CDK Inhibitors as Potential Treatment Option for Testicular Germ Cell Tumors. Cancers, 14(7), 1690.
https://doi.org/10.3390/cancers14071690